Sotac Pharmaceuticals Limited (NSE:SOTAC)
India · Delayed Price · Currency is INR 111.00
0.00 (0.00%)
May 27, 2026, 10:32 AM IST
Sotac Pharmaceuticals Revenue
In the fiscal year ending March 31, 2026, Sotac Pharmaceuticals had annual revenue of 1.02B INR with 1.33% growth. Sotac Pharmaceuticals had revenue of 322.88M in the quarter ending March 31, 2026, with 35.49% growth.
Revenue
1.02B
Revenue Growth
+1.33%
P/S Ratio
1.21
Revenue / Employee
8.00M
Employees
127
Market Cap
1.23B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.02B | 13.30M | 1.33% |
| Mar 31, 2025 | 1.00B | -37.09M | -3.57% |
| Mar 31, 2024 | 1.04B | 264.82M | 34.18% |
| Mar 31, 2023 | 774.83M | 43.32M | 5.92% |
| Mar 31, 2022 | 731.52M | 243.09M | 49.77% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Remus Pharmaceuticals | 8.54B |
| Accent Microcell | 3.56B |
| Infinium Pharmachem | 1.57B |
| Zenith Drugs | 1.44B |
| Quest Laboratories | 1.26B |
| Sunrest Lifescience | 520.34M |
| Medicamen Organics | 394.30M |
| Vilin Bio Med | 199.81M |